Thoracic perfusion of lobaplatin combined with endostar for treating malignant pleural effusions: A meta-analysis and systematic review
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000030749
Abstract: Introduction: Lobaplatin is a new platinum-based cytotoxic chemotherapeutic agent. Endostar is an endogenous angiogenic inhibitor with implicated anti-tumor activity. This study was to investigate the efficacy and safety of thoracic perfusion of lobaplatin combined with… read more here.
Keywords: lobaplatin combined; thoracic perfusion; odds ratio; lobaplatin ... See more keywords
The Meta-Analysis of Bevacizumab Combined with Platinum-Based Treatment of Malignant Pleural Effusions by Thoracic Perfusion
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Oncology"
DOI: 10.1155/2022/1476038
Abstract: Objective To evaluate the safety of bevacizumab combined with platinum-based thoracic perfusion for treating lung cancer-related malignant pleural effusion (MPE) through meta-analysis. Methods The CNKI, PubMed, Cochrane Library, Embase, Chinese Science and Technology Journal Database… read more here.
Keywords: meta analysis; bevacizumab combined; combined platinum; thoracic perfusion ... See more keywords